Demand for weight-loss medications balances price pressure, and Lilly increases its profit prediction
Strong demand for Lilly's GLP-1 weight-loss and diabetes medications helped offset declining prices in U.S. and foreign markets. Causing the...
Eli Lilly
Eli Lilly plans to pay up to $7 billion to purchase Kelonia Therapeutics
Eli Lilly, a U.S. pharmaceutical corporation, and Kelonia Therapeutics, a privately held biotechnology business. Reached an agreement on Monday to...
Trump is preparing new tariffs for some pharmaceutical companies
According to individuals familiar with the plan, Bloomberg News reported on Wednesday that the Trump administration intends to declare as...
Eli Lilly’s weight-loss pill has received FDA approval
Eli Lilly's new GLP-1 medication for weight loss, Foundayo, has received FDA approval. After Novo Nordisk's Wegovy was approved last...
Eli Lilly lowers the cost of its weight-loss medication, Zepbound
Eli Lilly dropped the cost of Zepbound on Monday after the pharmaceutical giant and Ozempic producer Novo Nordisk reached an...
